June 23, 2020 / 11:41 AM / 16 days ago

BRIEF-Imbruvica Seeks To Expand U.S. Label With Long-Term Data In Waldenström's Macroglobulinemia

June 23 (Reuters) - Abbvie Inc:

* IMBRUVICA® (IBRUTINIB) SEEKS TO EXPAND U.S. LABEL WITH LONG-TERM DATA IN WALDENSTRÖM’S MACROGLOBULINEMIA (WM)

* ABBVIE - APPLICATION SEEKS TO UPDATE IMBRUVICA U.S. PRESCRIBING INFORMATION BASED ON ANALYSIS OF OVER 5 YRS OF DATA FROM PHASE 3 INNOVATE CLINICAL TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below